CDK12-IN-6
Modify Date: 2025-08-26 18:48:19
CDK12-IN-6 structure
|
Common Name | CDK12-IN-6 | ||
|---|---|---|---|---|
| CAS Number | 2651196-71-1 | Molecular Weight | 425.44 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C20H21F2N9 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of CDK12-IN-6CDK12-IN-6, a pyrazolotriazine, is a potent CDK12 inhibitor with an IC50 of 1.19 μM at high ATP (2 mM). CDK12-IN-6 has no effect on CDK2/Cyclin E (IC50>20 μM) and CDK9/Cyclin T1 (IC50>20 μM) at high ATP (2 mM) (WO2021116178A1)[1]. |
| Name | CDK12-IN-6 |
|---|
| Description | CDK12-IN-6, a pyrazolotriazine, is a potent CDK12 inhibitor with an IC50 of 1.19 μM at high ATP (2 mM). CDK12-IN-6 has no effect on CDK2/Cyclin E (IC50>20 μM) and CDK9/Cyclin T1 (IC50>20 μM) at high ATP (2 mM) (WO2021116178A1)[1]. |
|---|---|
| Related Catalog | |
| Target |
CDK12:1.19 μM (IC50) CDK2/cyclinE:>20 μM (IC50) CDK9/cyclinT1:>20 μM (IC50) |
| In Vitro | CDK12-IN-6 (Example 174) inhibits BRCA1 MRNA expression in MDA-MB-231 cells (IC50=0.872 nM) and has no effect on CAL-120 cells[1]. CDK12-IN-6 has antproliferative activity in MDA-MB-231 cells (IC50=2.19 nM) and CAL-120 cells (IC50=1 nM)[1]. CDK12-IN-6 has a inhibition IC50 CDK12 high ATP to Degradation DC50 CDK12 ratio of 1851[1]. |
| References |
| Molecular Formula | C20H21F2N9 |
|---|---|
| Molecular Weight | 425.44 |
| InChIKey | BQWUTZRKMIAITL-UHFFFAOYSA-N |
| SMILES | Fc1ccc2[nH]c(CNc3nc(N4CCNCC4)nc4c(C5CC5)cnn34)nc2c1F |